POINT Biopharma Global (PNT) Q2 2023 Earnings

14AugConfirmed
Aug 22
Nov 22
Q1 2023
Q2 2023
-0.31
-0.26
-0.21
-0.16

Details

Expected EPS
-0.29
Actual EPS
-0.24
Surprise EPS
0.05
Surprise Percent
+17.24%

Description

POINT Biopharma Global (PNT) has reported earnings of -0.24 per share for Q2 2023.

0 Comments

Share your thoughts